The company
ImmunityBio, Inc.
IBRX · Nasdaq
IBRX stood above a rising 150-day average in 39 of the last 52 weekly readings, including each of the last 12 weeks. It is 8.3% above that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−12 points in four weeks); Health Care: 28% (−6 points in four weeks).
Statistics
- Rotation
- In trend
- Weeks in an uptrend
- 12 in a row
- Industry in uptrend
- 18% -12 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $17.9M
- Officials’ trades on record
- 3
- Institutions holding
- 387 (+21)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 39 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
3 disclosed lines: House 3, Senate 0, executive 0; 2 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Lisa C. McClain House: U.S. House ClerkMI09 | boughtspouse | $1k–$15k | 30 Sep 2026filed 12 Oct 2026 |
| Lisa C. McClain House: U.S. House ClerkMI09 | boughtspouse | $1k–$15k | 28 Sep 2026filed 12 Oct 2026 |
| Daniel S. Goldman House: U.S. House ClerkNY10 | sold | $1k–$15k | 6 Mar 2023filed 17 Apr 2023 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Barry J. SimonDirector | sold | 25,000at $10.75 | 5 Oct 2026filed 6 Oct 2026 |
| Cheryl CohenDirector | sold | 81,056at $10.50 | 2 Oct 2026filed 6 Oct 2026 |
| Cheryl CohenDirector | sold | 131,210at $9.50 | 2 Jul 2026filed 6 Jul 2026 |
| Christobel SeleckyDirector | sold | 159,478at $9.02 | 1 Jul 2026filed 6 Jul 2026 |
| Christobel SeleckyDirector | sold | 1,000at $9.00 | 30 Jun 2026filed 1 Jul 2026 |
| Christobel SeleckyDirector | sold | 95,722at $9.01 | 29 Jun 2026filed 1 Jul 2026 |
| Barry J. SimonDirector | sold | 25,000at $7.88 | 24 Jun 2026filed 26 Jun 2026 |
| Barry J. SimonDirector | sold | 23,033at $7.18 | 4 Jun 2026filed 5 Jun 2026 |
| Barry J. SimonDirector | sold | 75,000at $12.01 | 24 Feb 2026filed 26 Feb 2026 |
| Barry J. SimonDirector | sold | 165,000at $10.25 | 23 Feb 2026filed 24 Feb 2026 |
| Christobel SeleckyDirector | sold | 25,000at $10.00 | 23 Feb 2026filed 24 Feb 2026 |
| Barry J. SimonDirector | sold | 10,000at $9.25 | 20 Feb 2026filed 24 Feb 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 34,083,262$298.4M | +7,736,819+29.4% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 21,398,438$187.3M | +3,690,335+20.8% |
| VANGUARD PORTFOLIO MANAGEMENT LLCadded · filed 13 Aug 2026 | 17,863,911$156.4M | +1,541,067+9.4% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 15,691,579$137.4M | +563,865+3.7% |
| D. E. Shaw & Co., Inc.reduced · filed 14 Aug 2026 | 11,551,019$101.1M | -1,020,578−8.1% |
| TWO SIGMA INVESTMENTS, LPadded · filed 14 Aug 2026 | 11,097,106$97.2M | +6,711,606+153.0% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 9,847,896$86.2M | +1,815,975+22.6% |
| MILLENNIUM MANAGEMENT LLCadded · filed 14 Aug 2026 | 5,579,793$48.9M | +4,159,549+292.9% |
| NORTHERN TRUST CORPadded · filed 13 Aug 2026 | 3,565,248$31.2M | +1,060,467+42.3% |
| MORGAN STANLEYreduced · filed 13 Aug 2026 | 3,432,678$30.1M | -586,191−14.6% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.